These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32992230)

  • 1. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
    Liu Y; Justilien V; Fields AP; Murray NR
    Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
    Liu Y; Yin N; Wang X; Khoor A; Sambandam V; Ghosh AB; Fields ZA; Murray NR; Justilien V; Fields AP
    Cell Rep; 2020 Jan; 30(3):771-782.e6. PubMed ID: 31968252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
    Fields AP; Justilien V; Murray NR
    Adv Biol Regul; 2016 Jan; 60():47-63. PubMed ID: 26754874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
    Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
    Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.
    Yin N; Liu Y; Khoor A; Wang X; Thompson EA; Leitges M; Justilien V; Weems C; Murray NR; Fields AP
    Cancer Cell; 2019 Aug; 36(2):156-167.e7. PubMed ID: 31378680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.
    Justilien V; Walsh MP; Ali SA; Thompson EA; Murray NR; Fields AP
    Cancer Cell; 2014 Feb; 25(2):139-51. PubMed ID: 24525231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis.
    Wang Y; Hill KS; Fields AP
    Mol Cancer Res; 2013 Dec; 11(12):1624-35. PubMed ID: 24174471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.
    Justilien V; Fields AP
    Oncogene; 2009 Oct; 28(41):3597-607. PubMed ID: 19617897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma.
    Yang YL; Chu JY; Luo ML; Wu YP; Zhang Y; Feng YB; Shi ZZ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
    Genes Chromosomes Cancer; 2008 Feb; 47(2):127-36. PubMed ID: 17990328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
    Fields AP; Frederick LA; Regala RP
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
    Murray NR; Kalari KR; Fields AP
    J Cell Physiol; 2011 Apr; 226(4):879-87. PubMed ID: 20945390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer.
    Rehmani H; Li Y; Li T; Padia R; Calbay O; Jin L; Chen H; Huang S
    Signal Transduct Target Ther; 2020 Aug; 5(1):140. PubMed ID: 32820156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma.
    Erdogan E; Klee EW; Thompson EA; Fields AP
    Clin Cancer Res; 2009 Mar; 15(5):1527-33. PubMed ID: 19223491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic protein kinase Cι signaling mechanisms in lung cancer: Implications for improved therapeutic strategies.
    Yin N; Liu Y; Murray NR; Fields AP
    Adv Biol Regul; 2020 Jan; 75():100656. PubMed ID: 31623973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation.
    Justilien V; Jameison L; Der CJ; Rossman KL; Fields AP
    J Biol Chem; 2011 Mar; 286(10):8149-8157. PubMed ID: 21189248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C
    Kenchappa RS; Liu Y; Argenziano MG; Banu MA; Mladek AC; West R; Luu A; Quiñones-Hinojosa A; Hambardzumyan D; Justilien V; Leitges M; Sarkaria JN; Sims PA; Canoll P; Murray NR; Fields AP; Rosenfeld SS
    Cell Rep; 2021 Nov; 37(8):110054. PubMed ID: 34818553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer.
    Regala RP; Weems C; Jamieson L; Khoor A; Edell ES; Lohse CM; Fields AP
    Cancer Res; 2005 Oct; 65(19):8905-11. PubMed ID: 16204062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
    Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
    Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
    Regala RP; Davis RK; Kunz A; Khoor A; Leitges M; Fields AP
    Cancer Res; 2009 Oct; 69(19):7603-11. PubMed ID: 19738040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.